UBS Group »

Vistagen Therapeutics Ord shares owned by UBS Group

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $601 117 5.14
2023-09-30 $7.8k 1.5k 5.24
2023-06-30 $219 117 1.87

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Vanguard Group
Commodore Capital
Citadel Advisors
Sphera Funds Management
Susquehanna International
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
Gts Securities
William Blair $ Company

View all funds holding Vistagen Therapeutics Ord